Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. (SHA:600436)
China flag China · Delayed Price · Currency is CNY
138.11
-1.33 (-0.95%)
Aug 3, 2026, 3:00 PM CST

SHA:600436 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
1,9022,1592,9772,7972,4722,432
Depreciation & Amortization
120.59120.5994.6102.3880.36133.49
Other Amortization
8.518.519.9126.3115.3415.96
Loss (Gain) From Sale of Assets
-3.41-3.41-4.66-1.5-11.48-28.91
Asset Writedown & Restructuring Costs
-0.39-0.390.790.541.82.34
Loss (Gain) From Sale of Investments
-343.76-343.76-136.79-134.51-75.19-23.35
Provision & Write-off of Bad Debts
28.9528.952.9412.27-6.787.1
Other Operating Activities
649.7719.4460.289.36123.88100.42
Change in Accounts Receivable
-50.42-50.42272.9-181.924,258-2,089
Change in Inventory
-1,721-1,721-1,600-758.78-199.39-261.56
Change in Accounts Payable
-222.55-222.55-363.45306.43205.02232.58
Operating Cash Flow
451.0677.031,3142,2076,873462.27
Operating Cash Flow Growth
-73.44%-94.14%-40.47%-67.89%1386.79%-68.49%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-390.77-339.8-1,068-141.87-175.37-92.17
Sale of Property, Plant & Equipment
1.143.444.131.2513.745.31
Investment in Securities
2,1472,0472,354-2,658-6,170143.32
Other Investing Activities
352.9227.1234.5224.1227.0321.82
Investing Cash Flow
2,1101,7381,324-2,774-6,30578.29

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-5.014.9--1,410
Long-Term Debt Issued
-910.341,1611,1981,593-
Total Debt Issued
869.2915.351,1661,1981,5931,410
Short-Term Debt Repaid
------1,356
Long-Term Debt Repaid
--1,018-1,272-1,180-1,429-31.79
Total Debt Repaid
-925.2-1,018-1,272-1,180-1,429-1,387
Net Debt Issued (Repaid)
-56-102.31-106.317.85164.1223.09
Common Dividends Paid
-1,966-1,968-2,127-784.64-760.63-569.21
Other Financing Activities
4.08-4.67-6.98-2.5120.695.9
Financing Cash Flow
-2,018-2,075-2,241-769.3-575.82-540.23

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-7.42-2.268.162.4311.44-4.62
Net Cash Flow
536.27-261.67405.7-1,3343.84-4.29

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
60.28-262.77245.412,0656,698370.11
Free Cash Flow Growth
-89.25%--88.11%-69.17%1709.66%-64.69%
Free Cash Flow Margin
0.70%-2.92%2.27%20.53%77.04%4.61%
Free Cash Flow Per Share
0.10-0.440.413.4211.110.61
Levered Free Cash Flow
2,152-848.65-665.121,4111,3701,610
Unlevered Free Cash Flow
2,172-828.81-641.611,4341,3941,631

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
705.7771.851,1671,155989.67969.09
Change in Working Capital
-1,912-1,912-1,690-685.584,273-2,177